Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort StudyStéphanie Forté, Kevin H.M. Kuo, Dalton Budhram et al.|Journal of Clinical Medicine|2022Cited by 14
Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative ReviewIsmail A. Raslan, Jameel Abdulrehman, Ziad Solh et al.|Hemoglobin|2024Cited by 6
THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocolJameel Abdulrehman, Kevin H.M. Kuo, Stéphanie Forté et al.|BMJ Open|2024Cited by 4
Use of Thromboprophylaxis for Central Venous Access Devices in Patients with Sickle Cell Disease: A Survey of Canadian ProvidersKristine Matusiak, Kevin H.M. Kuo, Jameel Abdulrehman et al.|Blood|2021Cited by 2